FINNENCE ▪ THE WIRE FILE
THE WIRE · № 77353
News■ Unclear/unknown
Bambusa and Aspen join biotech IPO queue
KINDNews
DIRECTION■ Unclear/unknown
SOURCES4
ENTITIES1
STORY SIZE4 RECORDS
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Two more biotech names joining an IPO queue suggests improving issuance appetite, but no terms are disclosed.
Biotech listing pipeline building quietly
CATALYST TO WATCH
Filed terms and pricing ranges
MAIN RISK
Window can close on market volatility
02 THE STORY SO FAR
THE RECORD, IN ORDER.
UPDATED 4 TIMES · FIRST · LAST2026-10-13 09:41 UTCNewsContinuously Evolving Cells Help Pancreatic Cancer Evade Treatment and Spread
2026-10-13 10:23 UTCNewsBambusa and Aspen join biotech IPO queueCURRENT RECORD
2026-10-13 10:51 UTCNewsBambusa, Aspen and Tang added to IPO pipeline - pharmaphorum
2026-10-13 12:16 UTCNewsHorizon Space Acquisition and ArcheNova Biotech announce merger
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
An amendment to EUDA Health (EUDA)'s governing documents was filed on October 5, 2026.2026-10-13 10:30 UTC
An amendment to EUDA Health (EUDA)'s governing documents was filed on October 5, 2026.2026-10-13 10:30 UTC
→CORRELATIONshares Healthcare
Bambusa, Aspen and Tang added to IPO pipeline - pharmaphorum2026-10-13 10:51 UTC
Bambusa, Aspen and Tang added to IPO pipeline - pharmaphorum2026-10-13 10:51 UTC
→CORRELATIONshares Healthcare
AMSURG Partners with Euclid Endoscopy Center to Expand Access to Care in San Diego County2026-10-13 11:00 UTC
AMSURG Partners with Euclid Endoscopy Center to Expand Access to Care in San Diego County2026-10-13 11:00 UTC
→CORRELATIONshares Healthcare
Jocasta Neuroscience and Diamond Therapeutics Announce Research Program to Explore Non-Hallucinogenic Psychedelic-Inspired Compounds for Cognitive Impairment and Neurodegeneration2026-10-13 11:00 UTC
Jocasta Neuroscience and Diamond Therapeutics Announce Research Program to Explore Non-Hallucinogenic Psychedelic-Inspired Compounds for Cognitive Impairment and Neurodegeneration2026-10-13 11:00 UTC
→CORRELATIONshares Healthcare
RED QUEEN BIO APPOINTS IAN WATSON AS CHIEF GOVERNMENT AFFAIRS OFFICER2026-10-13 11:05 UTC
RED QUEEN BIO APPOINTS IAN WATSON AS CHIEF GOVERNMENT AFFAIRS OFFICER2026-10-13 11:05 UTC
→CORRELATIONshares Healthcare
125,000 restricted shares accompany FibroBiologics (FBLG)'s convertible debt offering.2026-10-13 10:03 UTC
125,000 restricted shares accompany FibroBiologics (FBLG)'s convertible debt offering.2026-10-13 10:03 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.